← Leaderboards
Sasha E. Larsen
Seattle Children'S Hospital
$349,467
Attributed
$698,933
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $267.6K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$698,933 · 2
By mechanism
R21$503,233 · 1
R03$195,700 · 1
Top collaborators
- Rhea N Coler4 shared
Most similar at Seattle Children'S Hospital
Same institution · by research overlap
- Christoph Grundner$14,681,687
- Lakshmi Rajagopal$23,879,900
Others in their field
Other Emerging Leaders on “Mycobacterium Tuberculosis”
- Kevin Urdahl · Seattle Children'S Hospital$86,597,961
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Thomas Dick · Rbhs-New Jersey Medical School$15,241,285
- Jay Evans · University Of Montana$12,765,004
- Sujatha Rashid · American Type Culture Collection$10,735,388
- Anna Upton · Global Alliance For Tb Drug Development$10,496,979
Research focus
Mycobacterium TuberculosisPre-ClinicalInfectionMycobacterialVaccinesUniversitiesFutureImmunityMethodologyMouse ModelPre-Clinical ModelPublishingTechnologyTuberculosisCellsDrug ResistanceGenus MycobacteriumHigh RiskIn VivoKineticsMorbidity - Disease RateMortalityResourcesBacterial Infections
Grant awards (4)
Cross development of surrogate efficacy mycobacterial growth inhibition assay endpoint for the translational guinea pig model$97,850
R03 · FY2025 · AI
Cross development of surrogate efficacy mycobacterial growth inhibition assay endpoint for the translational guinea pig model$97,850
R03 · FY2024 · AI
Advancing mycobacteriophage aerosol for prevention of pulmonary infections$235,625
R21 · FY2022 · AI
Advancing mycobacteriophage aerosol for prevention of pulmonary infections$267,608
R21 · FY2021 · AI